Focal Medical, Inc. (acquired by Continuity Biosciences)
Develops novel therapeutic products using a targeted system to deliver gemcitabine directly to the pancreas for treating pancreatic cancer.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
